O

Oramed Pharmaceuticals

D
ORMP
USD
0.035
(1.4957%)
Market Closed
7,876.00
Volume
0.24
EPS
-
Div Yield
4.65686
P/E
96,826,439.13
Market Cap
Today
1.4957%
1 Week
-0.210%
1 Month
-1.452%
6 Months
-1.042%
12 Months
14.183%
Year To Date
2.814%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
D
DVAX
-0.29
(-2.3577%)
USD
V
VBLT
-0.0114
(-6.6511%)
USD
O
OGEN
0.0124
(4.0208%)
USD
A
ARDX
-0.11
(-1.6936%)
USD
V
VKTX
3.91
(6.02%)
USD
K
KALV
-0.23
(-2.0193%)
USD

Title:
Oramed Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Do you need help or have a question?
Contact Us